Skip to main content

Politicians make promises on their stump — we watch and hold them accountable.

Help keep the record honest →Create an account
Bills/119th Congress · House

H.R. 7407

Introduced

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

Sponsor
DFrank Pallone, Jr.· New Jersey
Introduced
February 5, 2026
Policy area
Health
Latest action
Referred to the House Committee on Energy and Commerce.February 5, 2026
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7407 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 7407

To amend the Federal Food, Drug, and Cosmetic Act to establish new 
prohibited acts relating to dietary supplements.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

February 5, 2026

Mr. Pallone introduced the following bill; which was referred to the 
Committee on Energy and Commerce

_______________________________________________________________________

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to establish new 
prohibited acts relating to dietary supplements.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Prohibiting Tianeptine and Other 
Dangerous Products Act of 2026''.

SEC. 2. NEW PROHIBITED ACTS RELATING TO DIETARY SUPPLEMENTS.

(a) In General.--Section 301 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 331) is amended by adding at the end the 
following:
``(jjj) The introduction or delivery for introduction into 
interstate commerce of any product marketed as a dietary supplement 
that does not meet the definition of a dietary supplement under section 
201(ff).
``(kkk) The introduction or delivery for introduction into 
interstate commerce of a dietary supplement that has been prepared, 
packed, or held using the assistance of, or at the direction of, a 
person debarred under section 306.''.
(b) New Import Exclusion.--Section 801(a) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 381(a)) is amended in paragraph (3) 
of the third sentence, by striking ``section 301(ll)'' and inserting 
``paragraph (ll), (jjj), or (kkk) of section 301''.
(c) New Seizure Authorities.--Section 304 of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 334) is amended--
(1) in subsection (a)(1), in the first sentence, by 
striking ``section section 301(ll), 404, or 505'' and inserting 
``paragraph (ll), (jjj), or (kkk) of section 301, section 404, 
or section 505''; and
(2) in subsection (d)(1), in the first sentence, by 
inserting ``, or product in violation of paragraph (jjj) or 
(kkk) of section 301,'' after ``condemned under this section''.
<all>

Plain-language analysis

Not yet analyzed.

A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text above and the official source are the record.

StumpWatch is live, and the record is still growing. Many promises and positions aren’t tracked yet, and some features are still in beta. Add a sourced promise and help keep the record honest.

Help keep the record honest →